Mqs Management LLC Astrazeneca PLC Transaction History

Mqs Management LLC

$173 Million
Q1 2024

A detailed history of Mqs Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Mqs Management LLC holds 7,984 shares of AZN stock, worth $617,482. This represents 0.31% of its overall portfolio holdings.

Number of Shares

7,984

Holding current value

$617,482

% of portfolio

0.31%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$61.03 - $69.57 $487,263 - $555,446	7,984 New	7,984 $540,000
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $215,820 - $238,617	3,328 Added 64.48%	8,489 $574,000
Q2 2023 Aug 10, 2023	BUY	$69.91 - $75.81 $360,805 - $391,255	5,161 New	5,161 $369,000
Q3 2022 Nov 09, 2022	BUY	$53.02 - $135.75 $407,882 - $1.04 Million	7,693 Added 237.22%	10,936 $600,000
Q2 2022 Aug 05, 2022	BUY	$59.26 - $71.14 $192,180 - $230,707	3,243 New	3,243 $214,000

Q1 2022 May 10, 2022	SELL	$55.72 - $67.12 $333,149 - $401,310	-5,979 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$54.02 - $63.83 $322,985 - $381,639	5,979 New	5,979 $348,000

Others Institutions Holding AZN

# of Institutions

1,248

Shares Held

477M

Call Options Held

5.99M

Put Options Held

5.24M

Price T Rowe Associates Inc Baltimore, MD

61.3M
Shares

$4.74 Billion
0.51% of portfolio
Wellington Management Group LLP Boston, MA

49.1M
Shares

$3.8 Billion
0.6% of portfolio
Primecap Management CO Pasadena, CA

42.9M
Shares

$3.32 Billion
2.21% of portfolio
Capital International Investors Los Angeles, CA

34.5M
Shares

$2.67 Billion
0.48% of portfolio
Jennison Associates LLC

17.3M
Shares

$1.34 Billion
0.79% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $240B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mqs Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mqs Management LLC with notifications on news.

Account